Most Recent

Sexual Politics and Science: Two Predicaments

By | April 1, 2009

A Matter of Conscience Editor's Note (March 31). The April issue of The Scientist includes an Opinion entitled "A Matter of Conscience" in which Alexander McPherson laid out his objections to sexual harassment training at the University of California at Irvine. In the meantime McPherson has participated in the training, for reasons given in the update below. The Opinion article follows the update. My conflict with the University of Califo


The Economic Stimulus and Science

By | March 1, 2009

A fixed percentage of a country's GDP should be committed to research.


Time for an IP Share Market?

By | February 1, 2009

Direct investment in market-valued intellectual property could drive translational success.


Tackling Human Resources in Africa

By | January 1, 2009

How one institute leverages overseas talent to develop its research strategy.


Disease Prevention in Islamic Countries

By | November 1, 2008

A network of international experts is setting up a Supercourse to meet the challenge.


What Makes Science 'Science'?

By | October 1, 2008

Trainee teachers don't have a clue, and most scientists probably don't either. That's bad news.


Foundation-led Drug Discovery

By | September 1, 2008

Virtual biotechs target and develop translational research.


A Head Start

By | August 1, 2008

How an undergraduate internship helped a student from the projects explore his love of science.


More Women at the Top

By | August 1, 2008

One program's success in preparing and sustaining women for leadership in the sciences.


Mobilizing Students for Change

By | July 1, 2008

An organization focused on neglected diseases links trainees North and South.

1 Comment

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham